Hanson McClain Advisors »

Benitec Biopharma shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.0k 187 10.65

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds State Street Spd (SPDW)
Spdr Series Trust State Street Spd (SPYG)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds State Street Spd (SPEM)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Gmo Etf Trust Gmo Us Quality E (QLTY)

View all positions for Hanson McClain Advisors

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Franklin Resources
Adage Capital Partners GP
RA Capital Management
Nantahala Capital Management
BlackRock
Simplify Asset Management
Vanguard Capital Management
Infinitum Asset Management
Alyeska Investment Group
Silverarc Capital Management
Balyasny Asset Management
Millennium Management
Geode Capital Management

View all funds holding Benitec Biopharma